Science Explorer Back to mapMap
Discussion
Researcher · IntegraGen (France) · France

François Liebaert

François Liebaert publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Cancer Research, on topics such as Colorectal Cancer Treatments and Studies, Lung Cancer Treatments and Mutations and Gastric Cancer Management and Outcomes.

OpenAlex
World rank
#4,314,649
of 7,710,434 ranked researchers
Rank in France
#181,607
of 324,115
Works
22
Citations
218
Citations per work
9.9
h-index
6
i10-index 6Top 78% in Pulmonary and Respiratory Medicine
François Liebaert

What does François Liebaert research?

François Liebaert's work is mostly in Medicine (60%), Biochemistry, Genetics and Molecular Biology (25%).

Health Sciences: 13 works · 59.5% of their workMedicine: 13 works · 59.5% of their workPulmonary and Respiratory Medicine: 6 works · 26.9% of their workOncology: 6 works · 25.0% of their workGastroenterology: 1 works · 3.8% of their workRehabilitation: 1 works · 3.8% of their workLife Sciences: 6 works · 25.0% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 25.0% of their workCancer Research: 4 works · 17.3% of their workMolecular Biology: 2 works · 7.7% of their workEverything else: 3 works · 15.5% of their workTHEIR WORKFrançois Liebaert22works
Life Sciences25%Health Sciences60%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1359.5%
    1. Biochemistry, Genetics and Molecular Biology625.0%
  3. Everything else315.5%
  1. 1Pulmonary and Respiratory Medicine27% of their works
  2. 2Oncology25% of their works
  3. 3Cancer Research17% of their works
  4. 4Molecular Biology8% of their works
  5. 5Rehabilitation4% of their works
  6. 6Gastroenterology4% of their works

Research topics

Which keywords describe François Liebaert's research?

The keywords of their largest research topics: Chemotherapy, Cetuximab, KRAS Mutations, Targeted Therapy, ALK Inhibitors, EGFR Mutations, Clinical Practice Guidelines and Biogenesis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 21 words, with their numbers
  1. Chemotherapy162 topics
  2. Cetuximab121 topic
  3. KRAS Mutations121 topic
  4. Targeted Therapy122 topics
  5. ALK Inhibitors91 topic
  6. EGFR Mutations91 topic
  7. Clinical Practice Guidelines62 topics
  8. Biogenesis52 topics
  9. Regulation52 topics
  10. Endoscopic Resection41 topic
  11. Gastric Cancer41 topic
  12. Cancer Genomics31 topic
  13. Gene Expression31 topic
  14. MicroRNA31 topic
  15. Mutational Signatures31 topic
  16. Circular RNAs21 topic
  17. Hepatocellular Carcinoma21 topic
  18. Liver Cancer21 topic
  19. MicroRNA Sponges21 topic
  20. RNA methylation21 topic
  21. m6A-seq21 topic

Where does François Liebaert work?

François Liebaert's main affiliation in the publication record is IntegraGen (France), France.

How many publications and citations does François Liebaert have?

OpenAlex counts 22 works and 218 citations for François Liebaert, an h-index of 6, ranking #4,314,649 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about François Liebaert. Posts are plain text and can be reported.